{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:33:41Z","timestamp":1789749221678,"version":"4.0.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:00:00Z","timestamp":1295481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Radioimmunotherapy (RIT) has been shown to reduce the incidence of local recurrence of colorectal cancer in an experimental model. The aim of the present study was to investigate the survival benefit of RIT compared with chemotherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An anastomosis was constructed in male Wag\/Rij rats after intraluminal injection of CC531 tumour cells. The therapeutic efficacy of 177Lu-labelled MG1 (single intravenous dose of 300 MBq\/kg, n = 20) was compared with that of 5-fluorouracil-based chemotherapy (6 weekly cycles administered intraperitoneally, n = 20) and no treatment (n = 20). The primary endpoint was survival. Toxicity was monitored by bodyweight measurement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Both chemotherapy and RIT affected bodyweight, but the weight of animals in the RIT group remained significantly higher than in the chemotherapy group (median slope of bodyweight plot 0\u00b748 versus 0\u00b730 g\/day; P &amp;lt; 0\u00b7001). Kaplan\u2013Meier analysis showed that overall survival in the RIT and chemotherapy groups was significantly better than that in the control group (50 and 46 per cent versus 25 per cent respectively after 170 days; P = 0\u00b7024 and P = 0\u00b7029). Survival after treatment with RIT did not differ from that after chemotherapy (P = 0\u00b7911).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>RIT is as effective as chemotherapy in experimental colorectal cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs.7361","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T17:49:52Z","timestamp":1292435392000},"page":"436-441","source":"Crossref","is-referenced-by-count":5,"title":["Experimental study of radioimmunotherapy <i>versus<\/i> chemotherapy for colorectal cancer"],"prefix":"10.1093","volume":"98","author":[{"given":"G M","family":"de Jong","sequence":"first","affiliation":[{"name":"Department of Surgery, Division of Oncology and Abdominal Surgery, Radboud University Nijmegen Medical Centre , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R P","family":"Bleichrodt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Oncology and Abdominal Surgery, Radboud University Nijmegen Medical Centre , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Eek","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W J G","family":"Oyen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O C","family":"Boerman","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hendriks","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Oncology and Abdominal Surgery, Radboud University Nijmegen Medical Centre , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"2024092904523078800_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol"},{"key":"2024092904523078800_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bjs.1800810106","article-title":"Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy","volume":"81","author":"Abulafi","year":"1994","journal-title":"Br J Surg"},{"key":"2024092904523078800_bib3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/bjs.5349","article-title":"Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population","volume":"93","author":"Manfredi","year":"2006","journal-title":"Br J Surg"},{"key":"2024092904523078800_bib4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/BF02234390","article-title":"Identifying patients with T3\u2013T4 node-negative colon cancer at high risk of recurrence","volume":"44","author":"Burdy","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"2024092904523078800_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1245\/s10434-006-9243-1","article-title":"Loco-regional recurrence from colon cancer: a population-based study","volume":"14","author":"Sj\u00f6vall","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"2024092904523078800_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1072-7515(02)01224-3","article-title":"Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon","volume":"195","author":"Read","year":"2002","journal-title":"J Am Coll Surg"},{"key":"2024092904523078800_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejso.2010.05.007","article-title":"Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends","volume":"36","author":"Maggiori","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"2024092904523078800_bib8","first-page":"3232s","article-title":"Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study","volume":"5","author":"Behr","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2024092904523078800_bib9","first-page":"142","article-title":"Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts","volume":"54","author":"Blumenthal","year":"1994","journal-title":"Cancer Res"},{"key":"2024092904523078800_bib10","first-page":"1867","article-title":"Radioimmunotherapy is an effective adjuvant treatment modality after cytoreductive surgery of peritoneal carcinomatosis of colonic origin","volume":"47","author":"Koppe","year":"2006","journal-title":"J Nucl Med"},{"key":"2024092904523078800_bib11","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1245\/s10434-007-9509-2","article-title":"A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats","volume":"14","author":"Aarts","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"2024092904523078800_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/hyb.1997.16.101","article-title":"Radioimmunotherapy of solid tumors: a review \u2018of mice and men\u2019","volume":"16","author":"Behr","year":"1997","journal-title":"Hybridoma"},{"key":"2024092904523078800_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/bjs.6481","article-title":"Radioimmunotherapy prevents local recurrence of colonic cancer in an experimental model","volume":"96","author":"de Jong","year":"2009","journal-title":"Br J Surg"},{"key":"2024092904523078800_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1011062002851","article-title":"The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma","volume":"18","author":"Hagenaars","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"2024092904523078800_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006774602360","article-title":"The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy?","volume":"18","author":"Hagenaars","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"2024092904523078800_bib16","first-page":"1224","article-title":"Biodistribution and therapeutic efficacy of (125\/131)I-, (186)Re-, (88\/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin","volume":"45","author":"Koppe","year":"2004","journal-title":"J Nucl Med"},{"key":"2024092904523078800_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2007-963440","article-title":"[Influence of neoadjuvant chemotherapy on liver integrity and ischemic tolerance.]","volume":"46","author":"Manekeller","year":"2008","journal-title":"Z Gastroenterol"},{"key":"2024092904523078800_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00015458.2003.11679430","article-title":"Influence of neo-adjuvant chemotherapy with 5-fluorouracil on colonic anastomotic healing: experimental study in rats","volume":"103","author":"el-Malt","year":"2003","journal-title":"Acta Chir Belg"},{"key":"2024092904523078800_bib19","first-page":"342","article-title":"Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model","volume":"46","author":"Holmes","year":"1998","journal-title":"Toxicol Sci"},{"key":"2024092904523078800_bib20","first-page":"943","article-title":"5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat","volume":"18","author":"Mahteme","year":"1998","journal-title":"Anticancer Res"},{"key":"2024092904523078800_bib21","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.4103\/0973-1482.55139","article-title":"Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors","volume":"5","author":"Chatal","year":"2009","journal-title":"J Cancer Res Ther"},{"key":"2024092904523078800_bib22","first-page":"115S","article-title":"Perspectives on cancer therapy with radiolabeled monoclonal antibodies","volume":"46","author":"Sharkey","year":"2005","journal-title":"J Nucl Med"},{"key":"2024092904523078800_bib23","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/1078-0432.CCR-06-2436","article-title":"Optimization of radioimmunotherapy of solid tumors: biological impediments and their modulation","volume":"13","author":"Jain","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2024092904523078800_bib24","first-page":"814s","article-title":"Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors","volume":"50","author":"Jain","year":"1990","journal-title":"Cancer Res"},{"key":"2024092904523078800_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00259-005-1803-2","article-title":"Cancer radioimmunotherapy with alpha-emitting nuclides","volume":"32","author":"Couturier","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024092904523078800_bib26","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/cncr.10304","article-title":"Rationales, evidence, and design considerations for fractionated radio-immunotherapy","volume":"94","author":"DeNardo","year":"2002","journal-title":"Cancer"},{"key":"2024092904523078800_bib27","first-page":"400","article-title":"Pretargeted radioimmunotherapy of cancer: progress step by step","volume":"44","author":"Boerman","year":"2003","journal-title":"J Nucl Med"}],"container-title":["Journal of British Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.7361","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/98\/3\/436\/59424503\/bjs7361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/98\/3\/436\/59424503\/bjs7361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T04:52:42Z","timestamp":1727585562000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/98\/3\/436\/6148575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,20]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,1]]},"published-print":{"date-parts":[[2011,1,20]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.7361","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,3]]},"published":{"date-parts":[[2011,1,20]]}}}